add items to your
binder to email or
print all at once
Items In Binder
Site Lawyers
 

Andrew C. Elken

Partner, Corporate

Andrew C. Elken is a partner in Cravath’s Corporate Department. His practice primarily focuses on mergers and acquisitions, corporate governance and general corporate matters.

Mr. Elken’s clients have included Anheuser‑Busch InBev, Barnes & Noble, Cameron International, Credit Suisse, Crown Castle, Johnson & Johnson, Martin Marietta, Minerals Technologies, Mylan, Nalco, Novartis, Olin, Pinnacle Foods, Terra Industries, Unilever and WestRock.

Mr. Elken’s notable M&A transactions include representing:

  • Anheuser-Busch InBev in its $123 billion acquisition of SABMiller and the $12 billion sale of SABMiller’s U.S. and global Miller branded businesses to Molson Coors;
  • Cameron International in the creation of the OneSubsea joint venture with Schlumberger;
  • Credit Suisse in the approximately $700 million acquisition of all the Gulf of Mexico oil and gas assets of ATP Oil & Gas Corporation by Bennu Oil & Gas (Bennu Oil & Gas was formed by Credit Suisse and other lenders under ATP’s debtor‑in‑possession credit facility to effect the acquisition);
  • Crown Castle in its $1.5 billion acquisition of FiberNet and its $1 billion acquisition of NextG Networks;
  • Johnson & Johnson in the divestiture of its Global Orthopaedic Trauma business and its acquisition of Covagen;
  • Martin Marietta in its $3.2 billion acquisition of Texas Industries;
  • Minerals Technologies in its successful unsolicited $1.7 billion acquisition of AMCOL International following the announcement of a proposed acquisition of AMCOL by Imerys and a series of public competing bids by Minerals Technologies and Imerys;
  • Mylan in its: $9.9 billion acquisition of Meda; acquisition of the non‑sterile, topicals focused specialty and generics business of Renaissance Acquisition Holdings for $950 million in cash at closing plus additional contingent payments of up to $50 million; acquisition of the worldwide rights to a commercialized product for approximately $463 million; and $550 million acquisition of Bioniche Pharma;
  • Nalco in its $8.1 billion merger with Ecolab;
  • Novartis in its $470 million acquisition of Genoptix;
  • Olin in its $328 million acquisition of K.A. Steel Chemicals;
  • Pinnacle Foods in its $975 million acquisition of Boulder Brands;
  • Terra Industries in its defense against a hostile bid from CF Industries (which was withdrawn), its $4.6 billion proposed sale to Yara and the $5.2 billion topping bid by CF Industries;
  • Unilever in its $3.7 billion acquisition of Alberto‑Culver;
  • The Weinstein Company, after the removal of Harvey Weinstein, in the Chapter 11 bankruptcy sale of substantially all of the company’s assets to an affiliate of Lantern Asset Management for approximately $289 million; and
  • WestRock in its $4.9 billion acquisition of KapStone and its $2.28 billion acquisition of Multi Packaging Solutions.

Mr. Elken was recognized for his work in mergers and acquisitions by IFLR1000 in 2019.

Mr. Elken was born in New York, New York. He received an A.B. from Princeton University in 2004 and a J.D. from the University of Southern California School of Law in 2009, where he was a Frank Rothman Scholar, a member of the Order of the Coif and a Senior Editor of the Law Review. Mr. Elken joined Cravath in 2009 and became a partner in 2018.

Mr. Elken may be reached by phone at +1‑212-474-1414 or by email at aelken@cravath.com.

Mr. Elken is admitted only in New York.

Contact
+1 (212) 474-1414
+1 (212) 474-3700